Feedback
Settings

Settings

Goto Application

1. WO2020179780 - PENTACYCLIC HETEROCYCLIC COMPOUND

PermaLink
Publication Number WO/2020/179780
Publication Date 10.09.2020
International Application No. PCT/JP2020/008881
International Filing Date 03.03.2020
IPC
A61P 25/28 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 43/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
C07D 491/147 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/-C07D459/290
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
147the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
C07D 491/22 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/-C07D459/290
22in which the condensed system contains four or more hetero rings
C07D 495/22 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
22in which the condensed system contains four or more hetero rings
A61K 31/551 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
551having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
CPC
A61K 31/551
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
551having two nitrogen atoms, e.g. dilazep
A61P 25/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
C07D 491/147
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
12in which the condensed system contains three hetero rings
14Ortho-condensed systems
147the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
C07D 491/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
22in which the condensed system contains four or more hetero rings
C07D 495/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
22in which the condensed system contains four or more hetero rings
Applicants
  • エーザイ・アール・アンド・ディー・マネジメント株式会社 EISAI R&D MANAGEMENT CO., LTD. [JP]/[JP]
Inventors
  • 大橋　芳章 OHASHI Yoshiaki
  • 乗嶺　吉彦 NORIMINE Yoshihiko
  • 星川　環 HOSHIKAWA Tamaki
  • 吉田　融 YOSHIDA Yu
  • 小林　義久 KOBAYASHI Yoshihisa
  • 佐藤　信裕 SATO Nobuhiro
  • 萩原　幸司 HAGIWARA Koji
  • 佐藤　信明 SATO Nobuaki
  • 廣田　信介 HIROTA Shinsuke
  • 原田　尭明 HARADA Takaaki
  • 吉村　光 YOSHIMURA Hikaru
Agents
  • 長谷川　芳樹 HASEGAWA Yoshiki
  • 清水　義憲 SHIMIZU Yoshinori
  • 木元　克輔 KIMOTO Kosuke
Priority Data
2019-03935105.03.2019JP
Publication Language Japanese (ja)
Filing Language Japanese (JA)
Designated States
Title
(EN) PENTACYCLIC HETEROCYCLIC COMPOUND
(FR) COMPOSÉ HÉTÉROCYCLIQUE PENTACYCLIQUE
(JA) 五環式複素環化合物
front page image
Abstract
(EN) This compound represented by any one of formulae (I)-(XVII) or a pharmaceutically acceptable salt thereof has a cholinergic neuronal activation effect and is applicable as a therapeutic agent for cognitive impairment.
(FR) L'invention concerne un composé représenté par l'une quelconque des formules (I)-(XVII) ou un sel pharmaceutiquement acceptable de celui-ci, qui a un effet d'activation neuronale cholinergique et peut être appliqué en tant qu'agent thérapeutique pour une déficience cognitive.
(JA) 式（Ｉ）～（ＸＶＩＩ）で表される化合物またはその薬剤学的に許容される塩は、コリン作動性神経細胞賦活作用を有し、認知機能障害治療剤としての利用可能性を有する。
Related patent documents
US20200283452
AU2020232044
CA3129861
CN113453762
AR118235
BR112021015975
MYPI 2021004632
SG11202108780P
PE2021-1978
KR1020210135224
JPWO2020179780
EA202191966
EP3936190
IL285511
UAa202104623This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
NZ779034
CO20210010512
CL2021002144
MXMX/a/2021/009685This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
PH12021551955This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
RU2021123936This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau
# -